Human IgG4 Antibody

48305 100ul
EUR 429

Human Antibody Laboratories manufactures the anti human igg4 antibody reagents distributed by Genprice. The Anti Human Igg4 Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact human Antibody. Other Anti products are available in stock. Specificity: Anti Category: Human Group: Igg4 Antibody

Human IgG4 Antibody

100 ug
EUR 349.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

20 ug
EUR 153.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

7 ml
EUR 349.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

100 ug
EUR 349.3
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

100 ug
EUR 424.15
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

20 ug
EUR 186.15
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Human IgG4 Antibody

100 ug
EUR 424.15
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells.

Igg4 Antibody information

Human IgG4 Antibody

MBS9435166-5x01mL 5x0.1mL
EUR 1860

Anti-CD33 (Gemtuzumab), Human IgG4 Antibody

A1443-200 each
EUR 933.6

Anti-CD4 (Clenoliximab), Human IgG4 Antibody

A1091-200 each
EUR 874.8

Mouse Anti Human Igg4 Monoclonal Antibody

CABT-48879MH 0.2 mg
EUR 1057.2

Mouse anti Human IgG4 Monoclonal Antibody

MBS460956-01mg 0.1mg
EUR 320

Mouse anti Human IgG4 Monoclonal Antibody

MBS460956-5x01mg 5x0.1mg
EUR 1390

Anti-human IgG4 antibody

STJ15100190 250 µg
EUR 403.2
Description: This monoclonal antibody enables sensitive and specific detection of human IgG4 in ELISA and ELISpot. In ELISpot it is recommended as capture antibody when detecting with biotinylated antigen.

Anti-human IgG4 antibody

STJ15100191 250 µg
EUR 440.4
Description: This monoclonal antibody enables sensitive and specific detection of human IgG4 in e.g. antigen-specific ELISA.

Anti-Human IgG4 antibody

STJ16100443 1 mL
EUR 973.2

Anti-Human IgG4 Antibody

K06087M09G12C-100ug 100 ug
EUR 440
Description: Monoclonal Antibody

Anti-Human IgG4 Antibody

K06087M09G12C-1mg 1 mg
EUR 2200
Description: Monoclonal Antibody

Anti-Human IgG4 Antibody

K06087M09G12C-50ug 50 ug
EUR 308
Description: Monoclonal Antibody

Anti-Human IgG4 Antibody

K06216M03D08C-100ug 100 ug
EUR 360
Description: Monoclonal Antibody

Anti-Human IgG4 Antibody

K06216M03D08C-1mg 1 mg
EUR 1800
Description: Monoclonal Antibody

Anti-Human IgG4 Antibody

K06216M03D08C-50ug 50 ug
EUR 252
Description: Monoclonal Antibody

Anti-Human IgG4 Antibody

K06216M14H08C-100ug 100 ug
EUR 360
Description: Monoclonal Antibody

Anti-Human IgG4 Antibody

K06216M14H08C-1mg 1 mg
EUR 1800
Description: Monoclonal Antibody